Perimenopause and Menopause

Menopausal medicine has been underserved for two decades. Women are told to wait it out, offered SSRIs for hot flashes, and dismissed when they describe what they're actually experiencing. The medicine to do this well exists. The conversation just has to happen.

What patients tell us

“I'm 44. I'm not sleeping. My moods are unrecognizable. I'm gaining weight in my middle no matter what I do. I have anxiety I never had before. My cycles are unpredictable. My doctor says I'm 'too young' for menopause and my labs are 'normal' and to come back when I'm 50. Something is clearly happening and no one is helping me understand or address it.”

Why perimenopause is so often dismissed

Perimenopause — the transition period leading to menopause — typically begins in the 40s but can start earlier, and lasts anywhere from a few years to over a decade. The hormonal changes during this period are not gradual and linear; they're fluctuating and often chaotic. Estrogen and progesterone levels swing widely, and the resulting symptoms can be dramatic.

Mainstream medicine has substantially underserved women during this transition for decades. The Women's Health Initiative findings in 2002 produced a sharp decline in hormone therapy use that has been only partially corrected as the analysis matured. Many women now in their 40s and 50s have physicians trained during the post-WHI era of caution who don't engage substantively with menopausal medicine. The patient with perimenopausal symptoms often hears that her labs are 'normal,' that she's 'too young,' or that her symptoms can be managed with SSRIs and lifestyle counseling. This isn't medically defensible.

What perimenopause and menopause actually involve

Several distinct physiologic shifts occur: ovarian function declines progressively; progesterone production often drops earlier than estrogen; FSH rises irregularly; testosterone declines gradually. The symptoms are not limited to hot flashes — they include sleep disruption, mood changes, cognitive symptoms, joint pain, central weight gain, libido changes, genitourinary symptoms, cardiovascular shifts, and accelerating bone density loss. The transition also affects thyroid function, gut microbiome composition, mast cell activity, and the HPA axis.

How iHeal evaluates and treats this

Evaluation matches the clinical picture rather than fitting it to a single laboratory paradigm. Hormonal assessment considers estradiol, progesterone, FSH, LH, and testosterone — with awareness that single time-point measurements during perimenopause may miss the cyclical pattern. Thyroid, metabolic, inflammatory, and nutrient assessment complete the picture. Treatment is individualized: hormone therapy, when appropriate, uses bioidentical hormones at doses matched to the patient's needs. Beyond hormone therapy, the broader work — sleep, stress, gut health, the 5M framework, nutrient optimization, movement, and cardiovascular attention — matters substantially.

On bioidentical hormone therapy specifically

'Bioidentical' refers to hormones molecularly identical to those the body produces — estradiol, micronized progesterone, testosterone. The evidence base for bioidentical hormone therapy in appropriately selected patients is reasonable: transdermal estradiol does not carry the same venous thromboembolism risk as oral conjugated equine estrogens, and micronized progesterone is endometrially protective without the risks associated with synthetic progestins. The route, the specific hormones, and the doses matter. Bioidentical hormone therapy is not appropriate for all women, not without risks, and not the only intervention for menopausal symptoms — the treatment conversation is individualized rather than categorical.

Dr. Matthew Everett, MD

Pro Tip · From Dr. Everett

Matthew Everett, MDEnvironmental Medicine · IFMCP

Evaluation matches the clinical picture rather than fitting it to a single laboratory paradigm. Hormonal assessment considers estradiol, progesterone, FSH, LH, and testosterone — with awareness that single time-point measurements during perimenopause may miss the cyclical pattern. Thyroid, metabolic, inflammatory, and nutrient assessment complete the picture. Treatment is individualized: hormone therapy, when appropriate, uses bioidentical hormones at doses matched to the patient's needs. Beyond hormone therapy, the broader work — sleep, stress, gut health, the 5M framework, nutrient optimization, movement, and cardiovascular attention — matters substantially.

Sources & Further Reading

Concerned this applies to you?

A consultation is where we figure out whether perimenopause and menopause is actually contributing to your symptoms — and what to do about it.

On This Page

Perimenopause and Menopause

Menopausal medicine has been underserved for two decades. Women are told to wait it out, offered SSRIs for hot flashes, and dismissed when they describe what they're actually experiencing. The medicine to do this well exists. The conversation just has to happen.

What patients tell us

“I'm 44. I'm not sleeping. My moods are unrecognizable. I'm gaining weight in my middle no matter what I do. I have anxiety I never had before. My cycles are unpredictable. My doctor says I'm 'too young' for menopause and my labs are 'normal' and to come back when I'm 50. Something is clearly happening and no one is helping me understand or address it.”

Why perimenopause is so often dismissed

Perimenopause — the transition period leading to menopause — typically begins in the 40s but can start earlier, and lasts anywhere from a few years to over a decade. The hormonal changes during this period are not gradual and linear; they're fluctuating and often chaotic. Estrogen and progesterone levels swing widely, and the resulting symptoms can be dramatic.

Mainstream medicine has substantially underserved women during this transition for decades. The Women's Health Initiative findings in 2002 produced a sharp decline in hormone therapy use that has been only partially corrected as the analysis matured. Many women now in their 40s and 50s have physicians trained during the post-WHI era of caution who don't engage substantively with menopausal medicine. The patient with perimenopausal symptoms often hears that her labs are 'normal,' that she's 'too young,' or that her symptoms can be managed with SSRIs and lifestyle counseling. This isn't medically defensible.

What perimenopause and menopause actually involve

Several distinct physiologic shifts occur: ovarian function declines progressively; progesterone production often drops earlier than estrogen; FSH rises irregularly; testosterone declines gradually. The symptoms are not limited to hot flashes — they include sleep disruption, mood changes, cognitive symptoms, joint pain, central weight gain, libido changes, genitourinary symptoms, cardiovascular shifts, and accelerating bone density loss. The transition also affects thyroid function, gut microbiome composition, mast cell activity, and the HPA axis.

How iHeal evaluates and treats this

Evaluation matches the clinical picture rather than fitting it to a single laboratory paradigm. Hormonal assessment considers estradiol, progesterone, FSH, LH, and testosterone — with awareness that single time-point measurements during perimenopause may miss the cyclical pattern. Thyroid, metabolic, inflammatory, and nutrient assessment complete the picture. Treatment is individualized: hormone therapy, when appropriate, uses bioidentical hormones at doses matched to the patient's needs. Beyond hormone therapy, the broader work — sleep, stress, gut health, the 5M framework, nutrient optimization, movement, and cardiovascular attention — matters substantially.

On bioidentical hormone therapy specifically

'Bioidentical' refers to hormones molecularly identical to those the body produces — estradiol, micronized progesterone, testosterone. The evidence base for bioidentical hormone therapy in appropriately selected patients is reasonable: transdermal estradiol does not carry the same venous thromboembolism risk as oral conjugated equine estrogens, and micronized progesterone is endometrially protective without the risks associated with synthetic progestins. The route, the specific hormones, and the doses matter. Bioidentical hormone therapy is not appropriate for all women, not without risks, and not the only intervention for menopausal symptoms — the treatment conversation is individualized rather than categorical.

Dr. Matthew Everett, MD

Pro Tip · From Dr. Everett

Matthew Everett, MDEnvironmental Medicine · IFMCP

Evaluation matches the clinical picture rather than fitting it to a single laboratory paradigm. Hormonal assessment considers estradiol, progesterone, FSH, LH, and testosterone — with awareness that single time-point measurements during perimenopause may miss the cyclical pattern. Thyroid, metabolic, inflammatory, and nutrient assessment complete the picture. Treatment is individualized: hormone therapy, when appropriate, uses bioidentical hormones at doses matched to the patient's needs. Beyond hormone therapy, the broader work — sleep, stress, gut health, the 5M framework, nutrient optimization, movement, and cardiovascular attention — matters substantially.

Sources & Further Reading

Concerned this applies to you?

A consultation is where we figure out whether perimenopause and menopause is actually contributing to your symptoms — and what to do about it.

On This Page